HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nichola Cooper Selected Research

Inosine Triphosphate (ITP)

4/2022A Single-Arm, Long-Term Efficacy and Safety Study of Subcutaneous Romiplostim in Children with Immune Thrombocytopenia.
1/2022Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) network.
12/2021Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice.
12/2021Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia.
11/2021Immune thrombocytopenia.
9/2021Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia.
1/2021Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel.
1/2021Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.
1/2021International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee.
1/2021Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nichola Cooper Research Topics

Disease

56Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2022 - 03/2002
17Hemorrhage
11/2021 - 05/2006
9Infections
05/2022 - 02/2004
8Thrombocytopenia (Thrombopenia)
04/2021 - 10/2018
6COVID-19
05/2022 - 07/2020
5Autoimmune Diseases (Autoimmune Disease)
01/2021 - 04/2010
5Fatigue
01/2021 - 10/2018
4Inflammation (Inflammations)
04/2021 - 09/2014
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2013 - 02/2011
3Pneumonia (Pneumonitis)
05/2022 - 01/2021
3Thrombosis (Thrombus)
10/2021 - 12/2018
3Chronic Disease (Chronic Diseases)
01/2021 - 01/2017
3Aplastic Anemia (Anemia, Hypoplastic)
01/2021 - 01/2019
3Neoplasms (Cancer)
09/2014 - 08/2009
2Thrombotic Thrombocytopenic Purpura
11/2019 - 01/2017
2Leukemia
10/2017 - 01/2015
2Bronchiolitis Obliterans Syndrome
01/2017 - 09/2014
2Purpura
11/2015 - 05/2006
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2015 - 10/2014
2Human Influenza (Influenza)
07/2013 - 05/2011
2Multiple Myeloma
05/2011 - 09/2010
2Hematologic Neoplasms (Hematological Malignancy)
05/2011 - 02/2011
1Hereditary Hemorrhagic Telangiectasia
12/2022
1Iron Deficiencies
11/2022
1Severe Acute Respiratory Syndrome
05/2022
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2022
1Hypersensitivity (Allergy)
04/2021
1Venous Thromboembolism
04/2021
1Compartment Syndromes
01/2021
1Blister (Bulla)
01/2021
1Body Weight (Weight, Body)
01/2021
1Acute Radiation Syndrome
01/2021
1Liver Diseases (Liver Disease)
01/2021
1Weight Gain
11/2020
1Headache (Headaches)
11/2019
1Stroke (Strokes)
11/2019
1Abdominal Pain (Pain, Abdominal)
11/2019
1Lethargy
11/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2019
1Fibrosis (Cirrhosis)
01/2019

Drug/Important Bio-Agent (IBA)

47Inosine Triphosphate (ITP)IBA
04/2022 - 03/2002
9Rituximab (Mabthera)FDA Link
08/2012 - 04/2004
8romiplostimFDA Link
04/2022 - 10/2012
7Thrombopoietin ReceptorsIBA
04/2022 - 12/2015
6eltrombopagFDA Link
11/2022 - 07/2010
5AntibodiesIBA
10/2021 - 08/2012
5fostamatinibIBA
04/2021 - 01/2018
4Monoclonal AntibodiesIBA
01/2021 - 04/2004
3SteroidsIBA
09/2021 - 03/2002
3Pharmaceutical PreparationsIBA
04/2021 - 11/2007
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 10/2018
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2021 - 10/2014
3Intravenous Immunoglobulins (IVIG)FDA Link
12/2009 - 02/2004
3RHO(D) antibody (anti-D)IBA
12/2009 - 03/2002
2Thrombopoietin (c-mpl Ligand)IBA
11/2022 - 10/2012
2IronIBA
11/2022 - 10/2017
2tocilizumab (atlizumab)FDA Link
05/2022 - 01/2021
2AutoantibodiesIBA
01/2022 - 01/2020
2Immunoglobulin G (IgG)IBA
10/2021 - 01/2020
2Syk KinaseIBA
04/2021 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 02/2004
2Immunoglobulins (Immunoglobulin)IBA
07/2017 - 02/2004
2AntigensIBA
01/2017 - 08/2009
2Interleukin-10 (Interleukin 10)IBA
09/2014 - 02/2004
2CytokinesIBA
09/2014 - 02/2004
2Dasatinib (BMS 354825)FDA Link
07/2013 - 07/2012
1DNA (Deoxyribonucleic Acid)IBA
12/2022
1Chelating AgentsIBA
11/2022
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2022
1von Willebrand FactorIBA
10/2021
1Antigen-Antibody Complex (Immune Complex)IBA
10/2021
1SARS-CoV-2 spike proteinIBA
10/2021
1ruxolitinibIBA
04/2021
1Oxygen (Dioxygen)IBA
04/2021
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2021
1benzoyl L-arginine methyl ester (BAME)IBA
01/2021
1GlucocorticoidsIBA
01/2021
1CGP 43902AIBA
12/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2020
1Complement System Proteins (Complement)IBA
07/2020
1Vitamin DFDA LinkGeneric
07/2020
1Immunomodulating AgentsIBA
07/2020
1rozanolixizumabIBA
01/2020
1DisintegrinsIBA
11/2019
1Metalloproteases (Metalloproteinases)IBA
11/2019
1ThrombospondinsIBA
11/2019
1Reticulin (Reticular Fiber)IBA
01/2019
1Ribavirin (Virazole)FDA LinkGeneric
01/2019

Therapy/Procedure

18Therapeutics
01/2022 - 10/2007
6Stem Cell Transplantation
01/2022 - 02/2006
4Splenectomy
10/2018 - 03/2002
3Drug Therapy (Chemotherapy)
01/2021 - 05/2011
2Hematopoietic Stem Cell Transplantation
01/2017 - 10/2014
1Noninvasive Ventilation
04/2021
1Contraception (Birth Control)
04/2021
1Length of Stay
04/2021
1Artificial Respiration (Mechanical Ventilation)
04/2021
1Renal Replacement Therapy (Therapies, Renal Replacement)
04/2021
1Intravenous Infusions
01/2021
1Operative Surgical Procedures
01/2021